Clarity Pharmaceuticals and ImaginAb to collaborate on new cancer targets

Sydney, Australia and Los Angeles, California 21 July 2020 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the specificity of monoclonal antibodies, have entered into a collaboration agreement to develop new targeted theranostic (diagnostic and therapy) products for a broad range of cancer types.

Read more….


By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...